Annexon logo

Annexon

ANNX | NASDAQ
Chart Builder DCF Calculator
$3.57
-$0.35 (-8.93%)
At close: Nov 16, 2026, 4:00 PM ET
$3.62
+$0.05 (+1.40%)
After-hours: Nov 16, 2026, 7:30 PM ET
-8.93%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #771/1021 (Top 76%)

Key Statistics

Market Data

Market Cap $730.61M
1D Range
3.55 3.91
52W Range
3.02 6.96

Valuation (TTM)

PE -3.43
PB 5.12
EV/EBITDA -3.02

Valuation (NTM)

Forward PE N/A
Forward PEG 0.14
Price Target $14.00
Loading financial charts...

Profile

Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmi...

Sector Healthcare
Industry Biotechnology
Employees 92
IPO Date Jul 24, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$14.00
Upside
+292.16%
Buy (5)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.